CLB Stock Recent News

Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript

Core Laboratories (CLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

While the top- and bottom-line numbers for Core Laboratories (CLB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

In the investment space, uncovering stocks to sell with potential pitfalls is as crucial as identifying opportunities. This comprehensive review zooms in on the recent moves of three prominent companies that have sent ripples through the market.

Core Laboratories (CLB) anticipates revenues in the range of $125-$132 million and operating income in the band of $13.8-$17.3 million for the fourth quarter of 2023. It also expects earnings per share in the 17-23 cents range.

Although the revenue and EPS for Core Laboratories (CLB) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Crude price is now in its glorious days, calling for investment in energy companies like Matador Resources (MTDR), Pioneer Natural (PXD) and Core Laboratories (CLB).

The decisions of Saudi Arabia & Russia to voluntarily extend oil cuts until the year-end are aiding the crude rally. Solaris (SOI), Core Lab (CLB) and Evolution (EPM) are thus well-poised to gain.